This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Company. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovations of Sarah R Braford
Introduction
Sarah R Braford is a notable inventor based in Creve Coeur, MO (US). She has made significant contributions to the field of biotechnology, particularly in the area of peptide research. Her work has implications for the development of therapeutic proteins and hormones.
Latest Patents
Braford holds a patent for the "Release of recombinant peptides from polypeptides using V8 endopeptidase." This method allows for the extraction of heterologous peptides from fusion proteins, which include eucaryotic hormones such as atrial peptides. The patent also describes a novel DNA sequence encoding atrial peptide III, along with various genes, DNA vectors, endopeptidases, and transformed bacteria that are useful in practicing the method.
Career Highlights
Sarah R Braford is associated with Monsanto Company, where she has been able to apply her expertise in biotechnology. Her innovative approach has led to advancements in the production of recombinant peptides, which are crucial for various medical applications.
Collaborations
Throughout her career, Braford has collaborated with esteemed colleagues, including Marilyn S Mai and Michael L Bittner. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Sarah R Braford's contributions to biotechnology through her patent and work at Monsanto Company highlight her role as an influential inventor in the field. Her innovative methods for peptide release continue to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile